<?xml version="1.0"?>
<rss version="2.0">
<channel>

<title>PC Project - Spotlight &amp; News </title>
<description>Spotlight &amp; News</description>
<link>http://www.pachyonychia.org/index.php</link>




<item>
<title>GO Grant Awarded</title>
<description><![CDATA[Grand Opportunity (GO) Grant awarded for research to develop effective delivery of nucleic acids (siRNA) to skin.  ]]></description>
<link>http://www.pachyonychia.org/index.php</link>
</item>
<item>
<title>Patient Home Page</title>
<description><![CDATA[New Patient Home Page rolled out at 2009 Patient Support Meeting]]></description>
<link>http://www.pachyonychia.org/homePatient.php</link>
</item>
<item>
<title>Jan's Corner Update - Jul/Aug 2009</title>
<description><![CDATA[<Strong> Jan's Corner </strong> July/August 2009 Update. ]]></description>
<link>http://www.pachyonychia.org/PUBLIC/jansCorner.php</link>
</item>
<item>
<title>Clinical Study</title>
<description><![CDATA[<strong>Clinical Study </strong>. Dr. Peter Hull, Saskatchewan, Canada has received approval for a PC clinical study on an approved drug which may reduce keratin expression for PC patients. The study has been extended and expanded to additional patients.  ]]></description>
<link>http://www.pachyonychia.org/index.php</link>
</item>

</channel>
</rss>
